Your browser doesn't support javascript.
loading
CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure.
Abidi, Maheen Z; D'Souza, Anita; Kuppalli, Krutika; Ledeboer, Nathan; Hari, Parmeswaran.
Afiliación
  • Abidi MZ; Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: mabidi@outlook.com.
  • D'Souza A; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Kuppalli K; Division of Infectious Diseases, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA; Division of Infectious Diseases, Department of Medicine, Edward Hines, Jr. Veterans Administration Hospital, Hines, IL, USA.
  • Ledeboer N; Divison of Microbiology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hari P; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Diagn Microbiol Infect Dis ; 83(1): 46-8, 2015 Sep.
Article en En | MEDLINE | ID: mdl-25986028

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Aspergilosis / Aspergillus fumigatus / Voriconazol / Citocromo P-450 CYP2C19 / Antifúngicos Límite: Humans / Male / Middle aged Idioma: En Revista: Diagn Microbiol Infect Dis Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Aspergilosis / Aspergillus fumigatus / Voriconazol / Citocromo P-450 CYP2C19 / Antifúngicos Límite: Humans / Male / Middle aged Idioma: En Revista: Diagn Microbiol Infect Dis Año: 2015 Tipo del documento: Article
...